Study in mice suggests drug could bring new benefits in treating depression by lifting mood within hours, plus offer sustained effectiveness
For someone with depression in the midst of a crisis, there is no time to waste. Yet time is exactly what currently-available antidepressants require to take effect—often on the order of weeks.
A new study suggests a fast-acting antidepressant may be on the horizon. In mice, the drug produces evidence of a mood lift within 24 hours and then continues working for sustained relief.
“What makes this study unique and exciting is that in the same drug we seem to have both of the properties you want in an antidepressant—both rapid and sustained effects,” said Jeffery Talbot, Ph.D., director of the Research Center on Substance Abuse and Depression at Roseman University of Health Sciences and one of the study’s lead investigators.
Though many drugs are currently available to treat people with depression, existing drugs do not work quickly, and they do not work for everyone. “Many people with depression simply don’t respond to available medications,” said Talbot. “There’s still a real need for new antidepressants.”
The drug, referred to by Talbot as its coded name MI-4 and better known among scientists as Ro-25-6981, has been shown by previous researchers to cause a rapid antidepressant effect in animals by blocking one of the brain’s signaling chemicals. But until now, researchers were not aware of the full spectrum of its antidepressant properties.
The new study bolsters the evidence for MI-4’s rapid effect and adds an exciting twist: MI-4 also works in the long term. Moreover, it may accomplish its long-term effects through a three-pronged approach known as triple reuptake inhibition, which refers to a drug’s ability to simultaneously increase the levels of three key chemicals in the brain that are known to affect mood and feelings of pleasure—dopamine, norepinephrine and serotonin. Most depression drugs only target one of these chemicals, which may explain why they are not effective in all patients.
The researchers found MI-4 via “virtual screening,” a method that uses computer modeling to find drugs that are likely to interact with particular receptors in the brain. “From looking at its structure, one would never have guessed that this drug interacts with the same monoamine transporter proteins as does Paxil or cocaine, but it does. That speaks to the ‘needle in a haystack’ detection power of the virtual screening methodology,” said Christopher Surratt, Ph.D., a professor of pharmacology working on this aspect of the study at Duquesne University.
Following the virtual screening, the researchers tested MI-4’s effects in cell cultures and then in mice. In addition to providing new evidence of its antidepressant properties, the study shows MI-4 would be unlikely to become addictive.
Depression is one of the most common mental illnesses in the world, affecting about 20 million people in the United States. Causing persistent sadness and loss of energy, it can take an enormous toll on a person’s ability to work or have healthy personal relationships and is a leading cause of suicide.
Antidepressants are some of the most commonly prescribed medications, with 264 million prescriptions written for antidepressants in 2011 totaling more than $11 billion in sales.
The Latest on: Antidepressant
[google_news title=”” keyword=”Antidepressant” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Antidepressant
- Could This Toad’s Psychedelic Venom Be The Next Big Thing In Antidepressants?on May 9, 2024 at 1:15 am
B ehold the Colorado River toad. Also known as the Sonoran Desert toad, these bulbous fellas pack a psychedelic punch just below the surface. Their venom, which they can secrete through glands on ...
- Psychedelic Toad Venom Shows Promise for New Depression Treatmenton May 8, 2024 at 12:00 pm
Scientists have mapped the structure of a psychedelic drug derived from the Colorado River toad, which seems to have antidepressant effects.
- Psychedelics Activate Serotonin to Produce Antidepressant Effecton May 8, 2024 at 11:51 am
A new study advanced our understanding of how psychedelic drugs activate serotonin receptors to offer potential treatments for neuropsychiatric disorders.
- RNA blood test may predict antidepressant responseon May 8, 2024 at 3:57 am
The analysis by US biotech Circular Genomics focuses on an assay that looks for a circular RNA (circRNA) blood biomarker that the company says can predict response to sertraline, a commonly prescribed ...
- New York Times Sinks to New Low in Its Psychiatric Drug Coverageon May 7, 2024 at 5:00 pm
Establishment psychiatry, Big Pharma, and the mainstream media have acknowledged that a single antidepressant treatment does not work for the majority of patients; but for nearly twenty years, they ...
- Circular Genomics Announces New Research Demonstrating Accuracy of circRNA-based Test for Predicting Response to SSRI Antidepressant Treatmenton May 7, 2024 at 4:00 am
Circular Genomics, the global leader in circular RNA biomarkers for precision psychiatry and neurology, today announced study results published as a preprint on bioRXiv demonstrating the potential for ...
- Opinion: Can Ketamine Be Safely Used at Home?on May 5, 2024 at 9:08 pm
Ketabon is working to develop a medication that harnesses ketamine’s antidepressant effects without the safety issues that currently prohibit its at-home use.
- Magic Mushrooms Show Potency Against Depressionon May 4, 2024 at 11:24 pm
Findings are encouraging but further evidence is needed before any clinical recommendations can be made, say experts. Psilocybin — the active ingredient in “magic” mushrooms — is a more effective ...
- Potential for psilocybin antidepressant treatment highlighted by studyon May 4, 2024 at 11:08 pm
International scientists argue psilocybin could be used to treat depression on a larger scale but important questions remain unanswered.
- Depression Symptoms May be Treatable Using Psilocybin from Magic Mushroomson May 3, 2024 at 7:30 am
New research suggests that psilocybin, a compound found in magic mushrooms, may be effective in treating depression symptoms.
via Bing News